๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Small Lymphocytic Lymphoma
Clinical trial register · Israel

Small Lymphocytic Lymphoma Trials in Israel, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Israel and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 2428 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:47 UTC
2428
Studies in scope
all four open statuses
1246
Recruiting now
open to new participants
455
Lead sponsors
across recruiting studies
Top sites
Jerusalem 8 Tel Aviv 7 Haifa 6 Petah Tikva 6 Ramat Gan 6
Narrow the registerReset
Recruitment status
Phase
Site location
Jerusalem8 Tel Aviv7 Haifa6 Petah Tikva6 Ramat Gan6
All 13 locations
Target enrolment
to

Small Lymphocytic Lymphoma trials in Israel

15 of 2428 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Israel
Start
Not yet open
A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)
NCT07709000Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Hematologic Malignancies
Merck Sharp & Dohme LLC
Phase 2
60
Jerusalem, Ramat Gan, Tel Aviv
2026-09-25
Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT06973187Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
BeOne Medicines
Phase 3
500
Haifa, Jerusalem, KfarSava, Petah Tikva, Ramat Gan, Tel Aviv
2025-09-04
Active, closed
A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT06291220Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
AbbVie
Phase 1
4
แบ”erifin, Jerusalem, Ramat Gan
2025-01-27
Recruiting
Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
NCT06333262Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Inhye Ahn
Phase 2
60
2024-04-22
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
NCT06136559Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Merck Sharp & Dohme LLC
Phase 3
1,200
Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, แบ”erifin
2023-12-13
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
Loxo Oncology, Inc.
Phase 3
737
Jerusalem, Tel Aviv
2022-07-22
Active, closed
A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
NCT04965493Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Loxo Oncology, Inc.
Phase 3
600
Haifa, Nahariya, Petah Tikva, Rehovot, Tel Aviv
2021-09-20
Active, closed
Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT04666038Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Loxo Oncology, Inc.
Phase 3
238
Petah Tikva, Beersheba, Netanya, Tel Aviv, Haifa
2021-03-09
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naรฏve High Risk Chronic Lymphocytic Leukemia
Genmab
Phase 1/2
194
Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
2020-11-25
Recruiting
Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL
NCT04560322Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Massachusetts General Hospital
Phase 2
40
2020-10-19
Active, closed
Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia
NCT03701282Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
National Cancer Institute (NCI)
Phase 3
720
Jerusalem
2019-02-12
Active, closed
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
NCT02952508Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Cellectar Biosciences, Inc.
Phase 2
120
Jerusalem
2017-07-26
Active, closed
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT02048813Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
National Cancer Institute (NCI)
Phase 3
529
2014-03-10
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Janssen Research & Development, LLC
Phase 3
700
Afula, Hadera, Haifa, Petah Tikva, Ramat Gan, Tel Aviv
2013-09-09
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Israeli investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-israel/condition/small-lymphocytic-lymphoma

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Israel and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,428 studies in total at the last sync on 26 Sep 2026, 19:47 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies listing the condition Small Lymphocytic Lymphoma.

How many Small Lymphocytic Lymphoma trials are recruiting in Israel?

7 of the 15 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:47 UTC sync. A further 1 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Small Lymphocytic Lymphoma), 15 studies
PhaseStudiesRecruitingShare
Phase 39560%
Phase 24226.7%
Phase 1106.7%
Phase 1/2106.7%

Most active sponsors

Lead sponsors with the most studies (Small Lymphocytic Lymphoma)
Lead sponsorStudiesRecruiting
Loxo Oncology, Inc.31
BeOne Medicines22
Merck Sharp & Dohme LLC21
National Cancer Institute (NCI)20
AbbVie10
Cellectar Biosciences, Inc.10
Genmab10
Inhye Ahn11
Janssen Research & Development, LLC11
Massachusetts General Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.